ARCHIVES

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

This article is from The Cancer Letter archive.

Vol. 15 No. 23 | June 9, 1989

Download PDF Visit The Full Archive

Related Articles

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

April 27, 2012

NCI Lung Cancer Mutation Consortium: Screening For Mutations Can Focus Therapy

June 24, 2011

New Jersey Center Takes Slice of DOE Budget for Cancer

January 8, 1988

NCI Cooperative Group Clinical Trials Listed

April 24, 2009

Analysis Reveals CAIX Subgroup Responsive to Rencarex Therapy

June 28, 2013

“I’m Not Bummed Out By This” – Broder

December 22, 1994